Literature DB >> 25023627

Assessment of risk factors for developing incident aortic stenosis: the Tromsø Study.

Gry Wisthus Eveborn1, Henrik Schirmer, Per Lunde, Geir Heggelund, John-Bjarne Hansen, Knut Rasmussen.   

Abstract

To disclose risk factors of incident aortic stenosis (AS) and progression of established AS. A prospective cohort study. The Tromsø Study, a population based health survey. Over a 14 years span we performed three repeated echocardiographic examinations (1994, 2001 and 2008) of a random sample of initially 3,243 participants. Data from the only hospital serving this population were included in the follow up. Throughout the study 132 participants were diagnosed with incident AS, defined as mean aortic valve gradient ≥15 mmHg. Cox proportional hazards regression disclosed age (HR 1.11, 95 %CI 1.08-1.14), systolic blood pressure (BP) (HR 1.01, 95 % CI 1.00-1.02), active smoking (HR 1.71, 95 % CI 1.09-2.67), and waist circumference (HR 1.02, 95 % CI 1.00-1.03) as independent predictors of incident AS. Analysis of risk factors for progression of AS disclosed a higher mean aortic gradient at first measurement (p = 0.015), weight (p = 0.015), a low haemoglobin (Hgb) (p = 0.030) and high density lipoprotein (HDL) (p = 0.032) as significant independent predictors. Age, systolic BP, smoking and waist circumference were independent predictors of incident AS, whereas cholesterol was not. Mean aortic gradient at first measurement, weight, an elevated HDL and low Hgb increase the progression rate of the disease. Our data indicate that calcific aortic valve disease is a distinct pathophysiological process, with age, smoking and "wear and tear" of the valve being major contributors to the disease development.

Entities:  

Mesh:

Year:  2014        PMID: 25023627     DOI: 10.1007/s10654-014-9936-x

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  30 in total

1.  Association of coronary risk factors with progression of valvular aortic stenosis in older persons.

Authors:  D Nassimiha; W S Aronow; C Ahn; M E Goldman
Journal:  Am J Cardiol       Date:  2001-06-01       Impact factor: 2.778

Review 2.  Aortic stenosis: clinical aspects of diagnosis and management, with 10 illustrative case reports from a 25-year experience.

Authors:  Christopher E Kurtz; Catherine M Otto
Journal:  Medicine (Baltimore)       Date:  2010-11       Impact factor: 1.889

3.  Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population.

Authors:  Pia R Kamstrup; Anne Tybjærg-Hansen; Børge G Nordestgaard
Journal:  J Am Coll Cardiol       Date:  2013-10-23       Impact factor: 24.094

4.  Association between degenerative aortic valve disease and long-term exposure to cardiovascular risk factors: results of the longitudinal population-based KORA/MONICA survey.

Authors:  Jan Stritzke; Patrick Linsel-Nitschke; Marcello Ricardo Paulista Markus; Björn Mayer; Wolfgang Lieb; Andreas Luchner; Angela Döring; Wolfgang Koenig; Ulrich Keil; Hans-Werner Hense; Heribert Schunkert
Journal:  Eur Heart J       Date:  2009-07-16       Impact factor: 29.983

5.  Accelerated progression of calcific aortic stenosis in dialysis patients.

Authors:  Vlado Perkovic; David Hunt; Sian V Griffin; Moira du Plessis; Gavin J Becker
Journal:  Nephron Clin Pract       Date:  2003

6.  Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis.

Authors:  Kazuhiro Yamamoto; Hideya Yamamoto; Kiyoshi Yoshida; Akira Kisanuki; Yutaka Hirano; Nobuyuki Ohte; Takashi Akasaka; Masaaki Takeuchi; Satoshi Nakatani; Tomohito Ohtani; Takashi Sozu; Tohru Masuyama
Journal:  Hypertens Res       Date:  2010-01-08       Impact factor: 3.872

Review 7.  Is aortic stenosis a preventable disease?

Authors:  Kwan-Leung Chan
Journal:  J Am Coll Cardiol       Date:  2003-08-20       Impact factor: 24.094

Review 8.  Molecular and cellular mechanisms of aortic stenosis.

Authors:  Ertan Yetkin; Johannes Waltenberger
Journal:  Int J Cardiol       Date:  2009-04-21       Impact factor: 4.164

9.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample.

Authors:  M Lindroos; M Kupari; J Heikkilä; R Tilvis
Journal:  J Am Coll Cardiol       Date:  1993-04       Impact factor: 24.094

10.  Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Joachim H Ix; Michael G Shlipak; Ronit Katz; Matthew J Budoff; David M Shavelle; Jeffrey L Probstfield; Junichiro Takasu; Robert Detrano; Kevin D O'Brien
Journal:  Am J Kidney Dis       Date:  2007-09       Impact factor: 8.860

View more
  13 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

Review 2.  Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease.

Authors:  Alessandro Mantovani; Stefano Ballestri; Amedeo Lonardo; Giovanni Targher
Journal:  Dig Dis Sci       Date:  2016-01-25       Impact factor: 3.199

3.  Cumulative burden of clinically significant aortic stenosis in community-dwelling older adults.

Authors:  David S Owens; Traci M Bartz; Petra Buzkova; Daniele Massera; Mary L Biggs; Selma D Carlson; Bruce M Psaty; Nona Sotoodehnia; John S Gottdiener; Jorge R Kizer
Journal:  Heart       Date:  2021-06-02       Impact factor: 7.365

4.  Calcification Characteristics of Low-Flow Low-Gradient Severe Aortic Stenosis in Patients Undergoing Transcatheter Aortic Valve Replacement.

Authors:  Barbara E Stähli; Thi Dan Linh Nguyen-Kim; Cathérine Gebhard; Thomas Frauenfelder; Felix C Tanner; Fabian Nietlispach; Francesco Maisano; Volkmar Falk; Thomas F Lüscher; Willibald Maier; Ronald K Binder
Journal:  Cardiol Res Pract       Date:  2015-09-07       Impact factor: 1.866

Review 5.  Maternal obesity during pregnancy and cardiovascular development and disease in the offspring.

Authors:  Romy Gaillard
Journal:  Eur J Epidemiol       Date:  2015-09-16       Impact factor: 8.082

6.  The Generation R Study: design and cohort update 2017.

Authors:  Marjolein N Kooijman; Claudia J Kruithof; Cornelia M van Duijn; Liesbeth Duijts; Oscar H Franco; Marinus H van IJzendoorn; Johan C de Jongste; Caroline C W Klaver; Aad van der Lugt; Johan P Mackenbach; Henriëtte A Moll; Robin P Peeters; Hein Raat; Edmond H H M Rings; Fernando Rivadeneira; Marc P van der Schroeff; Eric A P Steegers; Henning Tiemeier; André G Uitterlinden; Frank C Verhulst; Eppo Wolvius; Janine F Felix; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2017-01-09       Impact factor: 8.082

7.  Overall and abdominal obesity and incident aortic valve stenosis: two prospective cohort studies.

Authors:  Susanna C Larsson; Alicja Wolk; Niclas Håkansson; Magnus Bäck
Journal:  Eur Heart J       Date:  2017-07-21       Impact factor: 29.983

8.  Elevated blood pressure and risk of aortic valve disease: a cohort analysis of 5.4 million UK adults.

Authors:  Kazem Rahimi; Hamid Mohseni; Amit Kiran; Jenny Tran; Milad Nazarzadeh; Fatemeh Rahimian; Mark Woodward; Terence Dwyer; Stephen MacMahon; Catherine M Otto
Journal:  Eur Heart J       Date:  2018-10-14       Impact factor: 29.983

9.  Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study.

Authors:  Susanna C Larsson; Magnus Bäck; Jessica M B Rees; Amy M Mason; Stephen Burgess
Journal:  Eur Heart J       Date:  2020-01-07       Impact factor: 35.855

10.  Genetic predisposition to smoking in relation to 14 cardiovascular diseases.

Authors:  Susanna C Larsson; Amy M Mason; Magnus Bäck; Derek Klarin; Scott M Damrauer; Karl Michaëlsson; Stephen Burgess
Journal:  Eur Heart J       Date:  2020-09-14       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.